Our data show high expression of ligand in many tumor clusters, including high CXCL12 in Tr11, CXCL2 in Tr3, and CXCL16 in Tr10 with high CXCR4 receptor expression in tumor endothelial cells supporting prior reports (Fig. 7d). The gene discussed is CXCL2; the disease is neoplasm.